SCHEMBL2764239

SCHEMBL2764239

COC(=O)CC(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL27467126 0.95 FAAH (0.52)
SCHEMBL27976 0.82 MGAM (0.61)
SCHEMBL28455549 0.80 FAAH (0.47)
SCHEMBL12305774 0.79
SCHEMBL12305750 0.79
SCHEMBL15688315 0.79 MGAM (0.58)
SCHEMBL1331006 0.79
SCHEMBL26568 0.79
SCHEMBL27515496 0.79 TSHR (0.50)
SCHEMBL1160631 0.79 TSHR (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115772137-A Preparation method of febuxostat 济宁晟泰药业有限公司 2023-03-10 CN claimed
CN-109053479-B Method for synthesizing quaternary amine inner salt 兆科药业(合肥)有限公司 2021-09-07 CN claimed
CN-102627596-B A kind of preparation method of Esomeprazole TIANJIN JINGYIN PHARMACEUTICAL BIOTECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2016-01-27 CN claimed
CN-102627596-A Preparation method of 4-hydroxy-2-oxo-1-pyrrolidine acetamide TIANJIN JINGYIN PHARMACEUTICAL BIOTECHNOLOGY DEV CO LTD 2012-08-08 CN claimed
US-20040248250-A1 Method for modifying enzyme and oxidoreductive variant KANEKA CORPORATION (JP) 2004-12-09 US claimed
EP-0967271-B1 NOVEL CARBONYL REDUCTASE, GENE THAT ENCODES THE SAME, AND METHOD OF UTILIZING THESE KANEKA CORP (JP) 2004-10-20 EP claimed
EP-1416050-A1 METHOD OF MODIFYING ENZYME AND OXIDOREDUCTASE VARIANT KANEKA CORPORATION (JP) 2004-05-06 EP claimed
US-6448052-B2 TO CONVERT ETHYL 4-CHLOROACETOACETATE USING NADPH AS A COENZYME TO PRODUCE ETHYL (S)-4-CHLORO-3-HYDROXYBUTYRATE; SUBSTRATE SPECIFICITY, NO ACTIVITY TO ETHYL ACETOACETATE, SPECIFIED OPTIMAL PH AND TEMPERATURE; ENZYME FROM CANDIDA KANEKA CORPORATION (JP) 2002-09-10 US claimed
US-20020006651-A1 Carbonyl reductase enzyme and methods for its use KANEKA CORPORATION 2002-01-17 US claimed
EP-0967271-A1 NOVEL CARBONYL REDUCTASE, GENE THAT ENCODES THE SAME, AND METHOD OF UTILIZING THESE KANEKA CORPORATION (JP) 1999-12-29 EP claimed
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-03-17 US disclosed
US-20230135772-A1 CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
CN-115772137-A Preparation method of febuxostat 济宁晟泰药业有限公司 2023-03-10 CN disclosed
EP-4130154-A1 CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT Asahi Kasei Kabushiki Kaisha (JP) 2023-02-08 EP disclosed
CN-115190901-A Carbodiimide composition, curing agent composition, coating composition, and resin cured product 旭化成株式会社 2022-10-14 CN disclosed
US-4008246-A Aminothiazole derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-02-15 US disclosed
US-4001425-A METHODS OF TREATING HYPERTENSION AND PHARMACEUTICAL COMPOSITIONS COMPRISING 1-TERTIARY-ALKYL-3-(SUBSTITUTED FURYL)UREAS AS ANTIHYPERTENSIVE AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-01-04 US disclosed
US-3969370-A 1-Tertiary-alkyl-3-(substituted furyl)ureas as antihypertensive agents E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-07-13 US disclosed
US-3965168-A CITRIC ACID INTERMEDIATE ETHYL CORPORATION (US) 1976-06-22 US disclosed
US-3960941-A CHEMICAL INTERMEDIATE FOR CITRIC ACID ETHYL CORPORATION (US) 1976-06-01 US disclosed